![The breaking news round-up: Decagear launches today, Pimax announces new headsets, and more! [APRIL FOOL’S]](https://i0.wp.com/skarredghost.com/wp-content/uploads/2025/03/lawk_glasses_handson.jpg?fit=1366%2C1025&ssl=1)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Boehringer Ingelheim said its experimental treatment for a chronic lung disease ...
Plus, news about Caliway Biopharmaceuticals, Orca Bio, Alterity Therapeutics and...
Roche's $8 billion InterMune acquisition, disclosed a decade ago, is now being h...
Pliant Therapeutics has slammed the brakes on enrollment and dosing in a mid-sta...
Plus, news about X4 Pharmaceuticals, Viracta Therapeutics, Crown Laboratories, Q...
It took one month for Johnson & Johnson to secure its $14 billion acquisition of...
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential ne...
AstraZeneca has terminated all development of vemircopan, the oral factor D inhi...
We’re in dealmaking season for publicly traded digital health companies. In ...
Almost 16 years after Rituxan's disappointing data in lupus, Roche's Genentech f...
A trade group representing 1,600 hospitals says 340B rebate models proposed by m...
After promoting its oncology officer Chris Boshoff to chief scientific officer l...
Personify Health, which sells healthcare spending management services to employe...
Bristol Myers Squibb is ending work on a handful of assets, including an immunol...
After running into clinical hurdles with its “diamond in the rough” strategy, Lo...
Cystic fibrosis biotech Sionna Therapeutics will raise $191 million in its upsiz...